Summary
Neutropenia in Felty's Syndrome predisposes patients to recurrent bacterial infections. We have treated a patient for more than one year with G-CSF and ascertained that this growth factor can savely correct neutropenia over a long periode of time. G-CSF may constitute a new agent for the treatment and prophylaxis of infection in Felty's syndrome.
This is a preview of subscription content, log in via an institution to check access.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Abdou NI (1983) Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome. Arthritis Rheum 26: 947–953
Hazenberg BPC, van Leeuwen M, van Rijswijk M (1989) Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis. Blood 74: 2769–2773
Joseph G, Neustadt DH, Hamm J, Kellihan M, Hadley T (1991) GM-CSF in the treatment of Felty syndrome. Am J Hematol 37: 55–56
Kaiser U, Klausmann M, Richter G, Pflüger K-H (1992) GM-CSF versus G-CSF in the treatment of infectious complication in Felty's syndrome — a cause report. Ann Hematol 64: 205–206
Markusse HM, Breedveld FC, Fibbe WE, Stern AC (1990) Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome. Arthritis Rheum 33: 1865–1867
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wandt, H., Seifert, M., Falge, C. et al. Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor. Ann Hematol 66, 265–266 (1993). https://doi.org/10.1007/BF01738478
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01738478